Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -27.82%225.27M | 15.42%648.69M | 5.67%312.08M | -24.66%562.04M | -32.81%295.34M | -19.48%745.95M | -20.73%439.57M | 7.28%926.47M | 16.33%554.52M | -19.33%863.63M |
| Operating income | -27.82%225.27M | 15.42%648.69M | 5.67%312.08M | -24.66%562.04M | -32.81%295.34M | -19.48%745.95M | -20.73%439.57M | 7.28%926.47M | 16.33%554.52M | -19.33%863.63M |
| Cost of sales | 30.09%-199.13M | -19.67%-584.49M | -12.79%-284.82M | 26.69%-488.43M | 36.19%-252.53M | 17.26%-666.26M | 20.29%-395.77M | -8.13%-805.28M | -19.88%-496.49M | 16.35%-744.72M |
| Operating expenses | 30.09%-199.13M | -19.67%-584.49M | -12.79%-284.82M | 26.69%-488.43M | 36.19%-252.53M | 17.26%-666.26M | 20.29%-395.77M | -8.13%-805.28M | -19.88%-496.49M | 16.35%-744.72M |
| Gross profit | -4.09%26.14M | -12.78%64.2M | -36.33%27.26M | -7.63%73.61M | -2.27%42.81M | -34.24%79.69M | -24.51%43.8M | 1.92%121.2M | -7.20%58.03M | -34.01%118.91M |
| Selling expenses | 36.03%-6.19M | -12.65%-27.01M | -18.37%-9.67M | -3.57%-23.97M | -21.12%-8.17M | 17.02%-23.15M | 40.55%-6.75M | 23.67%-27.9M | 15.85%-11.35M | -11.85%-36.54M |
| Administrative expenses | 1.65%-56.5M | -5.71%-100.94M | -42.06%-57.45M | -2.71%-95.49M | 25.76%-40.44M | 15.70%-92.97M | 17.89%-54.47M | -2.85%-110.29M | -27.57%-66.34M | 18.93%-107.23M |
| Research and development expenses | 26.33%-6.57M | 12.23%-22.87M | 27.70%-8.92M | -13.60%-26.06M | -2.48%-12.34M | 16.23%-22.94M | 15.90%-12.04M | 15.16%-27.38M | 11.03%-14.32M | 8.19%-32.28M |
| Revaluation surplus | ---- | 11,558.81%72.88M | 969.07%66.99M | -101.82%-636K | -606.51%-7.71M | 84.02%34.97M | -104.79%-1.09M | 169.51%19.01M | 625.90%22.76M | 324.44%7.05M |
| -Changes in the fair value of investment property | ---- | 11,558.81%72.88M | 969.07%66.99M | -101.82%-636K | -606.51%-7.71M | 84.02%34.97M | -104.79%-1.09M | 169.51%19.01M | 625.90%22.76M | 324.44%7.05M |
| Impairment and provision | -36.37%-2.29M | -138.99%-28.41M | 56.45%-1.68M | -212.92%-11.89M | -141.39%-3.86M | --10.53M | 2,471.50%9.32M | ---- | -104.32%-393K | ---- |
| -Goodwill impairment | ---- | ---16M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairment is provision | -36.37%-2.29M | -4.37%-12.41M | 56.45%-1.68M | -212.92%-11.89M | -141.39%-3.86M | --10.53M | 2,471.50%9.32M | ---- | -104.32%-393K | ---- |
| Operating interest expense | ---- | ---- | ---- | ---- | ---- | ---- | 0.33%-14.21M | ---- | 15.26%-14.26M | ---- |
| Special items of operating profit | 36.68%22.88M | 85.02%35.28M | -27.00%16.74M | -2.75%19.07M | -18.53%22.93M | -58.69%19.61M | 29.78%28.15M | 5.78%47.47M | 37.99%21.69M | 10.43%44.88M |
| Operating profit | -167.73%-22.53M | 89.50%-6.87M | 590.81%33.26M | -1,237.38%-65.37M | 7.04%-6.78M | -74.00%5.75M | -74.24%-7.29M | 524.46%22.11M | 47.25%-4.18M | -129.59%-5.21M |
| Financing cost | -5.33%-14.18M | -2.39%-29.36M | 9.47%-13.46M | -1.83%-28.68M | ---14.87M | -0.07%-28.16M | ---- | 5.69%-28.14M | ---- | 19.12%-29.84M |
| Share of profits of associates | ---- | 99.99%-4K | 99.98%-4K | -2.84%-46.72M | -103.29%-25.61M | -1,112.41%-45.43M | -229.26%-12.6M | -72.43%4.49M | 42.24%9.75M | 57.72%16.28M |
| Special items of earning before tax | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -677.40%-14.9M | ---- | 99.54%-1.92M |
| Earning before tax | -285.45%-36.71M | 74.26%-36.23M | 141.89%19.8M | -107.48%-140.76M | -137.63%-47.26M | -312.61%-67.84M | -457.57%-19.89M | 20.52%-16.44M | 615.00%5.56M | 95.18%-20.69M |
| Tax | 94.61%-962K | -640.57%-22.3M | -4,962.40%-17.85M | 132.55%4.13M | 129.86%367K | -29.08%-12.67M | 84.54%-1.23M | -212.61%-9.82M | -239.54%-7.95M | 43.36%-3.14M |
| After-tax profit from continuing operations | -2,031.85%-37.67M | 57.16%-58.54M | 104.16%1.95M | -69.70%-136.63M | -122.06%-46.89M | -206.60%-80.52M | -783.56%-21.12M | -10.22%-26.26M | 30.16%-2.39M | 94.52%-23.83M |
| Earning after tax | -2,031.85%-37.67M | 57.16%-58.54M | 104.16%1.95M | -69.70%-136.63M | -122.06%-46.89M | -206.60%-80.52M | -783.56%-21.12M | -10.22%-26.26M | 30.16%-2.39M | 93.29%-23.83M |
| Minority profit | 115.52%2.49M | -177.79%-27.97M | -939.17%-16.05M | -239.30%-10.07M | 295.30%1.91M | -258.33%-2.97M | 60.81%-979K | 92.63%-828K | -14.53%-2.5M | 71.84%-11.23M |
| Profit attributable to shareholders | -323.18%-40.16M | 75.85%-30.57M | 136.87%18M | -63.21%-126.57M | -142.35%-48.8M | -204.91%-77.55M | -18,746.30%-20.14M | -101.95%-25.43M | 108.70%108K | 96.01%-12.59M |
| Basic earnings per share | -323.29%-0.0326 | 83.19%-0.0248 | 114.72%0.0146 | 6.41%-0.1475 | -142.54%-0.0992 | -149.37%-0.1576 | -13,733.33%-0.0409 | -65.45%-0.0632 | -92.11%0.0003 | 60.21%-0.0382 |
| Diluted earnings per share | -323.29%-0.0326 | 83.19%-0.0248 | 114.72%0.0146 | 6.41%-0.1475 | -142.54%-0.0992 | -149.37%-0.1576 | -13,733.33%-0.0409 | -65.45%-0.0632 | -92.11%0.0003 | 60.21%-0.0382 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Auditor | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.